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OBJECTIVE—Signiﬁcant new data suggest that metabolic dis-
orders such as diabetes, obesity, and atherosclerosis all posses
an important inﬂammatory component. Inﬁltrating macrophages
contribute to both tissue-speciﬁc and systemic inﬂammation,
which promotes insulin resistance. The complement cascade is
involved in the inﬂammatory cascade initiated by the innate and
adaptive immune response. A mouse genomic F2 cross biology
was performed and identiﬁed several causal genes linked to type
2 diabetes, including the complement pathway.
RESEARCH DESIGN AND METHODS—We therefore sought
to investigate the effect of a C3a receptor (C3aR) deletion on
insulin resistance, obesity, and macrophage function utilizing
both the normal-diet (ND) and a diet-induced obesity mouse
model.
RESULTS—We demonstrate that high C3aR expression is found
in white adipose tissue and increases upon high-fat diet (HFD)
feeding. Both adipocytes and macrophages within the white
adipose tissue express signiﬁcant amounts of C3aR. C3aR
/
mice on HFD are transiently resistant to diet-induced obesity
during an 8-week period. Metabolic proﬁling suggests that they
are also protected from HFD-induced insulin resistance and liver
steatosis. C3aR
/ mice had improved insulin sensitivity on both
ND and HFD as seen by an insulin tolerance test and an oral
glucose tolerance test. Adipose tissue analysis revealed a striking
decrease in macrophage inﬁltration with a concomitant reduc-
tion in both tissue and plasma proinﬂammatory cytokine produc-
tion. Furthermore, C3aR
/ macrophages polarized to the M1
phenotype showed a considerable decrease in proinﬂammatory
mediators.
CONCLUSIONS—Overall, our results suggest that the C3aR in
macrophages, and potentially adipocytes, plays an important role
in adipose tissue homeostasis and insulin resistance. Diabetes
58:2006–2017, 2009
T
he complement system is an integral part of
both the innate and adaptive immune response
involved in the defense against invading patho-
gens (1). Complement activation culminates in
a massive ampliﬁcation of the immune response leading
to increased cell lysis, phagocytosis, and inﬂammation
(1). C3 is the most abundant component of the comple-
ment cascade and the convergent point of all three
major complement activation pathways. C3 is cleaved
into C3a and C3b by the classical and lectin pathways,
and iC3b is generated by the alternative pathway (2,3).
C3a has potent anaphylatoxin activity, directly trigger-
ing degranulation of mast cells, inﬂammation, chemo-
taxis, activation of leukocytes, as well as increasing
vascular permeability and smooth muscle contraction
(3). C3a mediates its downstream signaling effects by bind-
ing to the C3a receptor (C3aR), a Gi-coupled G protein–
coupled receptor. Several studies have demonstrated a
role for C3a and C3aR in asthma, sepsis, liver re-
generation, and autoimmune encephalomyelitis (1,3).
Therefore, targeting C3aR may be an attractive thera-
peutic option for the treatment of several inﬂammatory
diseases.
Increasing literature suggests that metabolic disor-
ders such as diabetes, obesity, and atherosclerosis also
possess an important inﬂammatory component (4–7).
Several seminal reports have demonstrated that resi-
dent macrophages can constitute as much as 40% of the
cell population of adipose tissue (7–9) and can signiﬁ-
cantly affect insulin resistance (10–18). Several proin-
ﬂammatory cytokines, growth factors, acute-phase
proteins, and hormones are produced by the adipose
tissue and implicated in insulin resistance and vascular
homeostasis (4–7,19). An integrated genomics approach
was performed with several mouse strains to infer
causal relationships between gene expression and com-
plex genetic diseases such as obesity/diabetes. This
approach identiﬁed the C3aR gene as being causal for
omental fat pad mass (20). The C3aR
/ mice were
shown to have decreased adiposity as compared with
wild-type mice on a regular diet (20). Monocytes and
macrophages express the C3aR (21–28). Increased C3a
levels also correlate with obesity, diabetes, cholesterol,
and lipid levels (29–34). We therefore sought to inves-
tigate the speciﬁc role of the C3aR in insulin resistance,
obesity, and macrophage function utilizing both normal
diet and the diet-induced obesity model.
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C3aR
/ mice generation, genotyping, and treatments. The C3aR
/
C57BL6 mice were generated by Deltagen (San Mateo, CA). The knockout and
heterozygous mice are in a pure C57BL6 background (backcrossed seven
times). All animals used in the studies were males, age matched (5–7 weeks
old, unless mentioned otherwise), and normalized for body weight. Mice were
fed either a normal diet (Teklad Global 2018; Harlan Teklad) composed of 6%
fat Kcal or high-fat diet (HFD) (D12492; Research Diet) composed of 60% fat
Kcal.
Measurements of plasma lipids, insulin, leptin, free fatty acids, ke-
tones, liver enzymes, and quantitative nuclear magnetic resonance.
Whole-blood insulin was measured using an insulin enzyme-linked immu-
nosorbent assay kit (Crystal Chem), according to the manufacturer’s protocol.
Free fatty acids (FFAs) and ketones were assessed from EDTA plasma using
the FFA Colorimetric Test and the Autokit Total Ketone Bodies (Wako
Diagnostics). Lipid proﬁle and liver enzymes were measured using an auto-
mated Vitros analyzer. Lean and fat content was determined by Echo3in1
quantitative nuclear magnetic resonance (qNMR) (EchoMedical Systems).
Histology and immunohistochemistry of adipose tissue and liver. Rout-
ing Mayer’s heamatoxylin and eosin staining was performed on white adipose
tissue (WAT) and liver sections (5 m) from all studied animals. F4/80
immunohistochemistry (IHC) was performed as described in ref. 8.
Liver triglyceride assay. Frozen liver (50 mg) samples were homogenized
in 1 ml of methanol by magnalyser homogenization (6,500 rpm  30 s; Roche).
Lipids were extracted as described in ref. 35. Triglyceride levels were assessed
using a serum triglyceride kit (no. TR0100-1KT; Sigma).
Western blot analysis. Tissue whole-cell extracts were obtained by magnal-
yser homogenization (Roche). A total of 100 mg of liver/muscle and 200 mg of
WAT were homogenized in 500 l of CHAPS lysis buffer. Antibodies were from
the following sources and used at a 1:1,000 dilution: -AKT and -AKT ser473
from Cell Signaling, -insulin receptor (IR) from Santa Cruz, -IR Tyr1162/
1163/1158 from Biosource, and -CD68 from AbD Serotec. Fujiﬁlm Multi-
Gauge V3 software was used for quantiﬁcation.
Adipose tissue fractionation. Equal amounts of epididymal WAT (eWAT)
were collected from mice. Tissue fractionation was performed as de-
scribed in ref. 8.
RNA extraction and quantitative PCR. RNA from tissues and fractions of
pelleted cells was extracted using an RNeasy lipid mini kit (Qiagen). RNA (1
g) was reverse transcribed using a Taqman reverse transcription reagent kit
(Applied Biosystem). Control RT reactions were also performed to assess
genomic DNA contamination. Quantitative real-time PCR was performed with
50 ng of the cDNA per reaction using the Taqman Fast Universal PCR Master
Mix (Applied Biosystem) on a 7900HT Fast Real-Time PCR System.
Macrophage isolation, polarization, and cytokine analysis. Bone marrow
cells were collected from femurs of ﬁve lean wild-type, C3aR
/, and C3aR
/
mice (6–7 weeks old) (14). Thioglycollate-elicited peritoneal macrophage
isolation was performed as described in ref. 28. Polarization was performed as
described in ref. 14. Cytokine expression from 30 ul of EDTA mouse plasma
and cell supernatants was measured using the MesoScale Discovery systems.
Both multiplex (interleukin [IL]-1, IL-2, IL-4, IL-6, IL-10, monocyte chemoat-
tractant protein [MCP]-1, KC/GRO, tumor necrosis factor-, RANTES, and
FIG. 1. C3aR mRNA expression is modulated by an HFD. Total RNA was extracted from various tissues from lean (n  10) and obese (n  10,
8–16 weeks on HFD) mice. A: Total eWAT, adipocyte-puriﬁed fraction, and the SVC fraction. B: Quantitative PCR on aP2/FABP4 (adipocyte
marker) and F4/80 (macrophage marker) conﬁrmed the proper isolation of each fraction. C: BAT. D: Muscle. E: Liver. F: Brain. mRNA expression
was examined by quantitative RT-PCR (Taqman) and normalized to cyclophilin B expression. Each PCR was performed in duplicate. The following
probes from Applied Biosystems were used: cyclophilin B, Mm00478295_m1; F4/80, Mm00802530_m1; CD68, Mm00839636_g1; and C3aR,
Mm02620006_s1 and Mm01184110_m1. *P < 0.05; **P < 0.01; ***P < 0.001 by unpaired t test.
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SI6000 plate reader. Samples were run in triplicate.
RESULTS
C3aR expression in tissues. The functions of both C3a
and the C3aR have been primarily investigated in the
context of an immune response; thus, analyses of comple-
ment components have focused largely on organs and cells
of the immune system. We therefore investigated C3aR
mRNA expression in a broad spectrum of tissues from
C57BL6 mice (see Fig. S1 in the online appendix [available
at http://diabetes.diabetesjournals.org/cgi/content/full/db09-
0323/DC1]). Literature suggests that C3a levels correlate
with obesity (31); we therefore investigated the expression
of the C3aR in C57BL6 mice after HFD. Interestingly, C3aR
mRNA expression was increased 13-fold in the eWAT from
mice on HFD (Fig. 1A). Subfractionation of the eWAT into
adipocyte fraction and stromal vascular cell (SVC) fraction
(mainly macrophages and preadipocytes) revealed that
C3aR expression was signiﬁcantly overexpressed in both
fractions (Fig. 1A). Quantitative RT-PCR for aP2/FABP4
(adipocyte marker) and F4/80 (macrophage marker) con-
ﬁrmed the proper isolation of each fraction (Fig. 1B). C3aR
expression was signiﬁcantly increased in brown adipose
tissue (BAT) (sixfold) (Fig. 1C). A slight increase in C3aR
expression was also seen in muscle (twofold) (Fig. 1D).
No increase in C3aR expression was seen in the liver,
brain, or pancreas of mice on HFD (Fig. 1E and F) (data
not shown). A striking note is that the expression level of
C3aR mRNA was signiﬁcantly higher in adipose tissue
(total and fractions) compared with all other tissues
(online appendix Fig. S2). C3aR expression was also
assessed in mouse 3T3-L1 adipocytes and several macro-
phage cell lines. Signiﬁcantly higher C3aR expression was
detected in the macrophage cell lines (online appendix
Fig. S8). We have also shown that C3aR mRNA is very
highly expressed in Kupffer cells while present in low
levels in hepatocytes and total liver (data not shown).
Interestingly, C3aR expression in both these cell types did
not vary after HFD (data not shown) unlike C3aR expres-
sion in the adipocyte and SVC fractions (Fig. 1A). These
data suggest that C3aR expression is high in adipose
tissue, particularly in the macrophage-containing fraction,
increases during HFD, and may play an important role in
adipose tissue function.
The effect of C3aR deﬁciency on diet-induced obesity.
To investigate the role of C3aR in insulin resistance and
obesity, a deletion of mouse C3aR was generated by the
insertion of a LacZ-neo cassette (online appendix Fig.
S3a). PCR conﬁrmed the proper disruption of the C3aR
gene (online appendix Fig. S3b). C3aR
/ mice generated
were normal, fertile, and showed no signiﬁcant pathophys-
iological defect (data not shown) (Deltagen). Quantitative
RT-PCR conﬁrmed the absence of C3aR mRNA in tissues
of C3aR
/ compared with wild-type mice (data not
shown). As expected, heterozygous mice also had a signif-
FIG. 2. The effect of C3aR deﬁciency on diet-induced obesity. The cohorts of C3aR
/, C3aR
/, and wild-type (WT) mice were initially age and
weight matched. A: Absolute body weight in grams over the 8-week period. B: Difference () in body weight gain in grams. C: Food intake in grams.
D: qNMR analysis of whole-body fat and lean tissue content expressed as a percent of total body weight was performed at 7 weeks of HFD. Data
for A–C are presented as means  SE (n  8–12 per group, except n  4 for
/). E: eWAT sections stained with hematoxylin and eosin with
adipocyte cell size measured by light microscopy (three sections per mice; n  6 per group). *P < 0.05; **P < 0.01; ***P < 0.001 by ANOVA. (A
high-quality digital representation of this ﬁgure is available in the online issue.)
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appendix Fig. S3c).
To investigate the role of the C3aR in insulin resistance
and obesity, knockout mice were put on an 8-week HFD.
Initially, the body weight of C3aR
/ and C3aR
/ mice at
5 weeks of age was not signiﬁcantly different compared
with the wild-type controls (Fig. 2A and B). The C3aR
/
mice gained on average 4–6 g (10–13%) less weight than
the wild-type mice during the ﬁrst 4 weeks of the study.
The C3aR
/ mice also showed an intermediate weight-
gain phenotype (2–3 g less than wild type) (Fig. 2A and B).
The resistance to weight gain observed in the C3aR
/ mice
was more pronounced early in the study and reduced to 3%
by 7 weeks on HFD. Terminal weights were equivalent in
all groups after 8 weeks on HFD (Fig. 2A and B). Three
independent diabetes-induced obesity studies conﬁrmed
the early resistance to weight gain, which attenuated over
time (online appendix Fig. S7 and data not shown).
Cumulative food intake on HFD was only slightly de-
creased in the C3aR
/ compared with wild type (Fig. 2C).
Other diabetes-induced obesity studies showed no effect
on food intake (online appendix Fig. S7 and data not
shown). To examine the effects on total fat depots and
lean mass, qNMR was performed. In contrast to normal-
diet (ND)-fed C3aR
/ mice, which had a decreased
fat-to-lean ratio, the C3aR
/ mice on HFD were not
discriminated from their wild-type counterparts (Fig. 2D).
The qNMR results reinforce the phenotype seen in
C3aR
/, where terminal weights on HFD were equivalent
to wild type (Fig. 2A and B). Furthermore, no signiﬁcant
difference in subcutaneous versus abdominal fat mass was
observed for all mice on HFD (data not shown). Adipose
tissue histology revealed a decrease in adipocyte size in
the C3aR
/ compared with wild type on both diets (Fig.
2E). Interestingly, the C3aR
/ mice on a ND gained less
weight (1–3 g less) over time compared with wild type
(Fig. 2A and B). In summary, C3aR
/ mice were initially
resistant to body weight gain on HFD, but this resistance
was transient and lost over time. This resistance is also
more signiﬁcant when mice are maintained on regular diet.
Metabolic proﬁle of C3aR
/ mice on HFD. To further
understand the phenotypic changes in the C3aR
/ mice,
several metabolic end points were investigated in lean and
obese C3aR
/ mice. Over the 8-week time course, blood
insulin levels were monitored. Between days 25 and 55, the
wild-type mice on HFD had between a two- and ﬁvefold
increase in insulin excursion compared with the C3aR
/
mice (Fig. 3A). In fact, insulin levels in the C3aR
/ mice
on HFD were normalized to wild-type mice on a regular
diet. The heterozygous mice on HFD also showed a
decreased insulin excursion, which was intermediate be-
tween the wild-type and C3aR
/ mice (Fig. 3A). Terminal
leptin and FFA levels were not signiﬁcantly altered in the
different groups on HFD (Fig. 3B and C). A signiﬁcant
decrease in leptin was observed in C3aR
/ mice on
regular diet compared with wild-type mice (Fig. 3B),
consistent with a decreased adiposity (Fig. 2D) (20). No
such effect on leptin was seen in all mice on HFD
consistent with the equivalent terminal body weights (Fig.
2A–C). An increase in terminal ketone bodies on HFD was
detected in the C3aR
/ mice (Fig. 3D). An effect on fatty
acid oxidation is unlikely in the C3aR
/ mice; no corre-
sponding effect on terminal FFA levels was observed (Fig.
3C) in conjunction with the signiﬁcant variation in the
ketone bodies measurement seen within each group on
HFD (Fig. 3E). Given the decreased insulin excursion in
FIG. 3. Metabolic proﬁle of C3aR
/ mice after 8 weeks on an HFD. A: Whole-blood insulin over an 8-week period. B: Terminal plasma leptin. C:
Terminal plasma FFAs. D: Terminal plasma ketones measured. Data are presented as means  SE (n  8–12 per group, except n  4 for
/).
Measurement performed in triplicate. *P < 0.05; **P < 0.01 by ANOVA.
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/ mice. Nine-week-old wild-type (WT) and C3aR
/ males (n  6 per group) for ITT on ND (A) and on an 8-week
HFD (B) were starved for 4 h and injected with one dose of insulin (0.3 units/kg i.p.). A: F, wild type; ‚, C3aR1
/ ND. B: F, wild type HFD; ‚,
C3aR
/ HFD. For OGTT, mice were starved for 24 h and then administered one dose of glucose (2 g/kg p.o.) on 2 weeks HFD (C) and on 8 weeks
HFD (D). C: F, wild type; ‚, C3aR
/. D: F, wild type HFD; ‚, C3aR
/ HFD. Blood glucose was measured from tail vein after 0, 20, 40, 60, and
120 min. AUC was calculated. *P < 0.05; **P < 0.01; ***P < 0.001 by ANOVA.
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/ mice during HFD (Fig. 3A), we performed an
insulin tolerance test (ITT) in order to clearly assess
insulin sensitivity (Fig. 4A and B). A signiﬁcant decrease in
blood glucose during the ITT was seen in the C3aR
/
mice on ND and HFD compared with wild-type mice. An
overall decrease in 16 and 20% blood glucose area under
the curve was seen in the C3aR
/ mice (Fig. 4A and B).
An oral glucose tolerance test (OGTT) also resulted in a
signiﬁcant decrease in blood glucose excursion in the
C3aR
/ mice (Fig. 4C and D). The decreased insulin
excursion on HFD (Fig. 3A) and the decreased glucose
excursion (Fig. 4) clearly demonstrate that the C3aR
/
mice are more insulin sensitive.
Several lipid parameters were also analyzed; a decrease
in total cholesterol was detected in the C3aR
/ mice on
HFD (Fig. 5A). No effect on triglycerides, HDL cholesterol,
or VLDL cholesterol was detectable (Fig. 5A). Plasma liver
enzymes aspartate transaminase and alanine transaminase
were also decreased in both the C3aR
/ and C3aR
/
mice on HFD (Fig. 5B). Liver triglyceride levels were also
measured; C3aR
/ on both ND and HFD had a signiﬁcant
reduction in liver triglyceride levels compared with wild
type (Fig. 5C). The C3aR
/ mice also showed a signiﬁcant
decrease in liver triglycerides on HFD (Fig. 5C). Liver
histology conﬁrmed that the C3aR
/ mice on both ND
and HFD had signiﬁcantly less lipid accumulation com-
pared with wild type (Fig. 5D). Both decreased liver
enzymes and liver triglycerides suggest decreased liver
steatosis. Overall, proﬁling of C3aR
/ mice suggests that
they are protected from HFD-induced insulin resistance as
seen by both metabolic proﬁling and increased insulin
sensitivity. Furthermore, these mice are also protected
from HFD-induced liver steatosis.
Insulin sensitivity of key metabolic tissues. To deter-
mine which tissues contributed to the increased insulin
sensitivity, we performed an acute in vivo insulin chal-
FIG. 5. Plasma lipids and liver enzyme proﬁles in the C3aR
/
mice after 8 weeks on HFD. A: Terminal plasma lipid proﬁle
measured (total cholesterol, triglycerides, HDL cholesterol,
and VLDL cholesterol assessed). B: Terminal plasma liver
enzymes AST and ALT measured. C: Terminal liver triglyceride
levels were assessed and normalized to the amount of liver
used. D: Liver sections stained with hematoxylin and eosin
stains (three sections per animal, n  6 per group). Data from
A and B presented as means  SE (n  8–12 per group, except
n  4 for
/). Measurements were performed in triplicate.
*P < 0.05; **P < 0.01 by ANOVA. (A high-quality digital
representation of this ﬁgure is available in the online issue.)
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muscle) on ND (Fig. 6A) and HFD (Fig. 6B). Both wild-type
and C3aR
/ mice (5–6 weeks old) were starved for 6 h,
after which a single dose of insulin was administered in
the peritoneum. Tissues were collected 5 min postdose,
and IR signaling was examined. Interestingly, an increased
IR chain and AKT phosphorylation and thus activation
was seen in both the liver and eWAT of lean C3aR
/ mice
upon challenge compared with wild type (2- to 2.5-fold
increase) (Fig. 6A, lanes 10–12 compared with lanes
4–6). Furthermore, the eWAT from vehicle-treated
C3aR
/ animals also possessed a slightly increased basal
AKT phosphorylation (Fig. 6A, lanes 7–9 compared with
lanes 1–3), also suggesting increased insulin sensitivity.
An increased AKT phosphorylation was seen in the liver
and eWAT of C3aR
/ mice on HFD upon challenge
compared with wild type (5.6- and 2-fold increase) (Fig.
6B, lanes 10–12 compared with lanes 4–6). Increased IR
chain phosphorylation was more evident in WAT (2.5-fold)
(Fig. 6B, lanes 10–12 compared with lanes 4–6). The
C3aR
/ mice showed an intermediate phenotype (Fig. 6B,
lanes 13–15). No signiﬁcant change in IR signaling was
seen in muscle (Fig. 6A and B). In all, these results suggest
that C3aR
/ mice are more insulin sensitive, both bio-
chemically and as demonstrated by the ITT and OGTT
challenges (Figs. 4 and 6).
Macrophage inﬁltration in adipose tissue. Several
recent studies (4–7) have demonstrated an important role
for adipose tissue macrophages (ATMs) in mediating
insulin resistance during obesity. These studies have
shown that macrophages can be polarized to two states
(36). Interestingly, M1 macrophages (classical proinﬂam-
matory) have been shown to increase in the obese insulin-
resistant adipose tissue, while M2 (alternative anti-
inﬂammatory) are mostly present in lean insulin-sensitive
WAT (4–8,36). We therefore investigated the function of
macrophages in the C3aR
/ mice. Macrophage inﬁltra-
tion in the adipose tissue was assessed by quantifying the
levels of two macrophage markers (F4/80 and CD68) (37).
Staining of adipose tissue sections with an anti-F4/80
antibody revealed a signiﬁcant decrease in macrophage
inﬁltration in WAT from C3aR
/ mice on HFD (Fig. 7A).
Typical crown-like structures (several macrophages sur-
rounding an adipocyte) usually present in obese insulin-
resistant WAT (8) were virtually absent in C3aR
/
adipose tissue after 8 weeks of HFD (Fig. 7A). Analysis of
WAT proteins by immunoblot with CD68-speciﬁc antibod-
ies conﬁrmed the results seen by the F4/80 IHC. As
FIG. 6. Acute insulin challenge in C3aR
/ mice. Wild-type (WT) and C3aR
/ mice (5–6 weeks old) on ND (A) and HFD (6 weeks) (B) were
starved for6h( n  6 per group) and injected with one dose of insulin (0.3 units/kg i.p.) or vehicle. Five minutes postinjection, tissues were
collected (liver, skeletal muscle [gastrocnemius], and eWAT). Tissues were homogenized and protein extracted and analyzed by SDS-PAGE.
Nitrocellulose membranes were probed with antibodies: -IR -chain, -IR -chain phosphoTyr1162/Tyr1163, -AKT, and -AKT phosphoSer473.
Each lane represents tissue protein extract from one individual animal. Fold increase is calculated by dividing the signal intensity of the
phosphorylated protein by the signal intensity of the total protein. Fold changes in protein phosphorylation were graphed. *P < 0.05; **P < 0.01;
***P < 0.001 by ANOVA.
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seen in wild-type mice on HFD compared with ND (six-
fold) (Fig. 7B, lanes 7–9 compared with lanes 1–3).
Interestingly, CD68 protein expression was signiﬁcantly
lower in eWAT from C3aR
/ or C3aR
/ on HFD as
compared with wild-type HFD (2- and 2.7-fold decrease)
(Fig. 7B, lanes 10–14 compared with lanes 1–3); CD68
levels in C3aR
/ mice on HFD were similar to those seen
in mice on ND (Fig. 7B, lanes 10–14 compared with lanes
1–6). Liver CD68 expression was unchanged after HFD in
all mice (data not shown). Quantitative PCR analysis of
CD68 and F4/80 mRNA expression (Fig. 7C) conﬁrmed the
CD68 immunoblot and F4/80 IHC results.
We also investigated the expression pattern of M1- and
M2-speciﬁc genes within the adipose tissue: MCP-1 and
IL-6 are adipokines believed to initiate macrophage inﬁl-
tration in the WAT and involved in systemic insulin
resistance (rev. in 5,18). Indeed, a signiﬁcant increase in
MCP-1 mRNA levels was seen in wild-type mice on HFD
compared with ND (fourfold) (Fig. 7D). MCP-1 expression
in C3aR
/ mice on HFD was 1.7-fold lower than wild-type
controls. Interestingly, C3aR
/ on ND also had a 1.8-fold
lower MCP-1 mRNA expression compared with wild type
on ND consistent with decreased adiposity (Fig. 7D). A
deﬁnitive trend toward decreased IL-6 expression was
seen in both the C3aR
/ and C3aR
/ mice on HFD
compared with wild type (Fig. 7D). We investigated the
expression of M2-speciﬁc genes. Arginases are overex-
pressed in M2 macrophages and believed to be involved in
adipose tissue repair (37). Adipose tissue from C3aR
/
mice on ND showed a dramatic increased in Arg2 (Fig.
7D). Arg2 levels are also increased in the knockout mice
on HFD to a lesser extent than on ND. No change in other
M2-speciﬁc genes (Arg1, Mrc2, Mgl1, Mgl2, and Ym1) was
detected in eWAT (data not shown). We also investigated
the expression of several adipogenesis genes (peroxisome
proliferator–activated receptor [PPAR], CD36, LPL, DGAT1,
and aP2) as well as fatty oxidation genes (uncoupling pro-
FIG. 6. Continued.
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abdominal WAT of wild-type and C3aR
/ mice on ND and
HFD. No signiﬁcant difference was observed in the expres-
sion of these genes in both fat depots (data not shown).
Furthermore, no signiﬁcant difference in the expression of
thermogenesis-related genes, uncoupling protein-1, and
PPAR coactivator-1 in BAT was observed in these mice.
Lastly, no signiﬁcant changes in M1 and M2 gene expression
FIG. 7. Macrophage inﬁltration and gene expression proﬁle in the eWAT after 8 weeks on HFD. A: Sections of eWAT (three sections per animals,
n  6 per group) were ﬁxed and stained with a -F4/80 antibody (macrophage marker). Fluorescence microscopy was used to visualize
macrophages (red) surrounding adipocytes. Nuclei (green) were stained by DAPI. B: Total eWAT was homogenized and proteins extracted and
analyzed by SDS-PAGE. Each lane represents eWAT protein extract from one individual animal. Nitrocellulose membranes were probed with
-CD68 (macrophage marker) and -AKT (loading control) antibodies. Fold increase in CD68 is calculated by dividing the signal intensity of the
CD68 protein by the signal intensity of AKT. Fold changes in CD68 protein levels were graphed. RNA was extracted from eWAT and quantitative
RT-PCR performed for CD68 and F4/80 (C) and MCP-1, IL-6, and Arg2 mRNA expression (D). All reactions were done in duplicate. Data presented
as means  SE (n  8–12 per group, except n  4 for
/). All PCR were performed in duplicate. mRNA expression was normalized to cyclophilin
B. The following probes from Applied Biosystems were used: cyclophilin B, Mm00478295_m1; F4/80, Mm00802530_m1; CD68, Mm00839636_g1;
MCP-1/CCL2, Mm00441242_m1; IL-6, Mm00446190_m1; Arg2, Mm00477592_m1; Arg1, Mm00475988_m1; C3aR, Mm02620006_s1 and
Mm01184110_m1. *P < 0.05; **P < 0.01; ***P < 0.001 by ANOVA. (A high-quality digital representation of this ﬁgure is available in the online
issue.)
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suggest that adipose tissue from C3aR
/ mice has a de-
creased M1 gene expression proﬁle.
Both local and systemic proinﬂammatory cytokines
have been shown to signiﬁcantly affect insulin sensitivity
of the WAT, liver, and muscle. We therefore examined if
the local increase in IL-6 and MCP-1 mRNA expression
(Fig. 7D) correlated with an increased plasma cytokine
expression (online appendix Fig. S4). As expected, a
signiﬁcant increase in proinﬂammatory cytokines was
seen in wild-type mice after 8 weeks of HFD compared
with ND (online appendix Fig. S4). Interestingly, no such
increase in proinﬂammatory mediators was seen in the
C3aR
/ mice on HFD; the levels were comparable to both
wild-type and C3aR
/ mice on ND (online appendix Fig.
S4). Consequently, the decreased adipose tissue inﬂamma-
tion (Fig. 7) also translates to a decreased systemic
inﬂammation (online appendix Fig. S4), thus potentially
affecting the insulin responsiveness of other tissues.
To understand the role of C3aR in macrophage biology,
bone marrow–derived macrophages (BMDMs) from lean
wild-type, C3aR
/, and C3aR
/ mice were generated
and polarized to M1 and M2. Strikingly, both C3aR
/ and
C3aR
/ M1 BMDMs produced considerably fewer proin-
ﬂammatory cytokines compared with wild type (online
appendix Fig. S5a). We further investigated the gene
expression pattern of other M1 and M2 genes (online
appendix Fig. S5b). Both C3aR
/ and C3aR
/ M1 BM-
DMs possessed a considerable decreased expression of
both Nos1, Nos2, and MARCO (M1 markers) compared
with wild type (online appendix Fig. S5b). The expression
of several M2 markers (Arg1, Arg2, Mgl1, Mgl2, Ym1, and
MRC2) (37) were unchanged (data not shown). Similar
results were obtained with thioglycollate-elicited perito-
neal macrophages from wild-type and C3aR
/ mice. A
signiﬁcant decrease in M1 markers was seen in the
C3aR
/ peritoneal macrophages (online appendix Fig.
S6). No effect on M2-speciﬁc markers mentioned above
was observed (data not shown). Our results demonstrate
that C3aR deletion decreases proinﬂammatory cytokines
and M1-speciﬁc gene expression in macrophages.
DISCUSSION
Combined genetics, expression analysis, and a systems
biology approach using an intercross between several
mouse strains were used to identify causal genes involved
in tissue adiposity and potential insulin resistance. One of
the striking causal genes identiﬁed was the C3aR (20).
Utilizing knockout mice, we describe a novel role for the
C3aR in adipose tissue homeostasis with implications for
metabolic syndrome (Fig. 8). This study shows that the
C3aR is highly expressed in both adipocytes and macro-
phages and signiﬁcantly increases in the WAT after HFD
(Figs. 1 and online appendix Fig. S2). C3aR
/ mice were
only transiently resistant to body weight gain on HFD (Fig.
FIG. 8. Model of the role of the C3aR in IR and liver steatosis. Macrophages in the periphery and in tissues (adipose tissue, liver) play an
important role in inﬂammation. Proinﬂammatory mediators produced by resident macrophages, adipocytes, and hepatocytes stimulate the
inﬁltration of circulating monocytes within the tissue, which differentiate into macrophages. The increased local inﬂammation affects the insulin
responsiveness of the tissue and other organs, thus leading to systemic insulin resistance. The C3aR is highly expressed in both adipocytes and
macrophages.
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phenotype on ND described by Schadt et al. (20) was also
recapitulated in this study (Fig. 2). Furthermore, the
C3aR
/ mice are protected from HFD-induced insulin
resistance and liver steatosis (Fig. 8). Adipose tissue
analysis of C3aR
/ mice on HFD revealed a striking
decrease in macrophage inﬁltration with a concomitant
reduction in both tissue and plasma proinﬂammatory
cytokine production (Figs. 7 and online appendix Fig. S4).
This decreased macrophage inﬁltration may provide the
rationale for decreased adipocyte size seen in C3aR
/ as
compared with wild type on HFD. We also show that
ATMs, BMDMs, and thioglycollate-elicited peritoneal mac-
rophages express signiﬁcantly fewer proinﬂammatory M1
mediators compared with wild type (Figs. 7 and online
appendix Figs. S5 and S6). Interestingly, the C3aR
/ mice
on ND have signiﬁcant increased insulin sensitivity (Fig.
4A). Our results suggest that C3aR is most likely causal for
insulin resistance. This is quite striking and may be
indicative of a more pronounced role of macrophages
and/or inﬂammatory genes in insulin resistance.
ATMs have emerged as crucial contributors to both
local (tissue-speciﬁc) and systemic inﬂammation
(9,19,39,40). In this study, we clearly demonstrate that
macrophage inﬁltration in the adipose tissue is signiﬁ-
cantly diminished in the C3aR
/ mice on HFD (Fig. 7).
Macrophages possess different activation states; shifting
the balance from M1 to M2 macrophages in adipose tissue
appears to be beneﬁcial to in vivo insulin sensitivity
(14,16,17). A clear role of macrophage function in insulin
resistance has been demonstrated by the macrophage-
speciﬁc PPAR
/ mice (16,17). We also show that mac-
rophage M1 function is signiﬁcantly diminished in the
C3aR
/ ATMs, BMDMs, and thioglycollate-elicited peri-
toneal macrophages (Figs. 7D and online appendix Figs.
S5 and S6). Both local (adipose tissue) and systemic
inﬂammation are greatly decreased in the C3aR1
/ mice
on HFD (Figs. 7 and online appendix Fig. S4). Overall, the
signiﬁcant decrease in WAT M1 macrophages and their
decreased proinﬂammatory potential may be sufﬁcient to
promote insulin sensitivity. Currently, anti-inﬂammatory
agents such as salicylates are being tested in large clinical
trials to determine whether they are efﬁcacious in obese
diabetic subjects with respect to insulin sensitization (41).
Initial data seem to suggest that salicylates can improve
glycemia and decrease inﬂammatory parameters elevated
in nondiabetic obese adults (42,43). Thus, targeting inﬂam-
mation through the modulation of resident macrophage
functions may have a signiﬁcant impact on metabolic
disorders.
C3a desArg is a cleavage product of C3a, which acts on
a novel receptor, C5L2, to stimulate triglyceride synthesis
in the adipose tissue (rev. in 44). The C3
/ mice (the
precursor of C3a, C3a desArg, C3b, and iC3b) were gener-
ated and showed to have increased FFA as well delayed
postprandial clearance of triglycerides on ND and HFDs
(45). No signiﬁcant change in body weight was seen in
male C3
/ after 16 weeks on HFD (46). Interestingly, only
once the C3
/ were crossed to ob/ob mice was signiﬁcant
resistance to body-weight gain observed (47). They also
had lower insulin levels and signiﬁcantly lower homeosta-
sis model assessment index, which was related to their
decreased body weight. Therefore, a more pronounced
body-weight phenotype in C3aR
/ mice may manifest
itself in a leptin-deﬁcient background. Strikingly, we show
that the C3aR
/ mice on ND have a consistent resistance
to adiposity, and this may explain their increased insulin
sensitivity. The role of C3, C3a desArg, and our data on the
C3aR provide a clear role of the complement system in
negatively impacting adiposity and insulin sensitivity.
With the growing worldwide epidemic in both diabetes
and obesity, demands for new therapies are increasing.
The complexities of these diseases, which involve multiple
organs, add to the difﬁcult task of developing new treat-
ments. Understanding the biology and identifying new
druggable targets is a major effort within the pharmaceu-
tical industry. Advances in genomics have helped in iden-
tifying potential key drivers of complex traits involved in
these diseases (20). The ﬁeld of insulin resistance and
inﬂammation is still in its infancy. Development of novel
therapeutics which interfere with key causal nodes such
as the complement pathway may provide a critical link
between inﬂammation and insulin resistance.
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